Hello again Jimwalden,
Below you will find the results of my research for this question.
2005 venture capital investments into biotech went up 5% from 2004 to $7.3 bln.
?MPM Capital led the top 10 venture firms by number of investments
during 2005, having participated in 17 investments, followed by Alta
Partners, Domain Associates and HealthCap, each with 15 investments?
ZDNet Research
http://blogs.zdnet.com/ITFacts/?p=9909
====================================
Healthcare Corporate Finance News announces that health care venture
capital funding reaches highest level in three years.
?During the year ended December 31, 2005, the size of the health care
venture capital market grew to nearly $7.3 billion invested.?
?Compared with 2004, the amount of total dollars invested increased by
more than 5%.?
?The total number of health care venture capital deals increased by
11% in 2005, compared with 2004.?
Sector Venture Capital Deals
Biopharmaceuticals $2.1 billion 102
Medical Devices $1.4 billion 97
Pharmaceuticals $1.4 billion 70
Biotechnology $1.3 billion 86
Health Care Venture Capital Deal and Dollar Volume
Year Number of Deals Total Funding, in Billions
2003 386 $5.5
2004 399 $6.9
2005 443 $7.3
-------------------------------
Top 10 Venture Capital Firms,
By Participation in Number of
Health Care Investments
-------------------------------
QUARTER ended December 31, 2005
-------------------------------
Firm Investments
-------------------------------
3i 5
Abingworth 5
Alta Partners 4
Canaan Partners 4
CDIB 4
InterWest Partners 4
MPM Capital 4
ProQuest Investments 4
Venrock Associates 4
HBM funds 4
-------------------------------
-------------------------------
Top 10 Venture Capital Firms,
By Participation in Number of
Health Care Investments
-------------------------------
YEAR ended December 31, 2005
-------------------------------
Firm Investments
-------------------------------
MPM Capital 17
Alta 15
Domain 15
HealthCap 15
3i 11
HBM funds 11
Montreux 11
SV Life Sciences 11
Abingworth 10
Frazier Healthcare 10
Yahoo Finance: January 2006
http://biz.yahoo.com/prnews/060112/nyth100.html?.v=38
====================================
At the link below you will find informative profiles for over 80
Venture Capital Firms Active in the Medical Device Field
http://www.devicelink.com/links/venture.html
Some examples:
MPM Capital
?MPM Capital is the manager for the $230 million BioVentures family of
venture capital funds that are invested in parallel in selected
private healthcare companies in the US and Europe. BB Bioventures LP
investments range from $5 million to $20 million. The current
portfolio includes manufacturers of surgical sealants, diabetes
management systems, hearing aids, and transdermal drug-delivery
systems.?
Alta Partners
?Alta Partners prefers to act as the lead investor, taking a board
seat, and assisting the company as it develops. Typically, between $2
million and $8 million is invested in a company throughout the life of
the investment. Focus is on the West Coast.?
Domain Associates
?Domain Associates provides $30 million to $40 million annually to
US-based ventures concentrating in the life sciences. Current
portfolio includes some well-known device firms, including developers
of tumor-ablation devices, wearable defibrillators, minimally invasive
surgical instruments, and surgical vision systems.?
See complete list and profiles here:
http://www.devicelink.com/links/venture.html
===================================
Company Profiles - 2005 Top 10 List
===================================
-----------
MPM Capital
-----------
?MPM Capital is the world's largest dedicated investor in life
sciences. With committed capital under active management of more than
$2 billion, MPM Capito is uniquely structured to invest globally in
healthcare innovation.?
http://www.mpmcapital.com/flash/home.html
MPM Investments in Biotechnology and Biopharmaceuticals
http://www.mpmcapital.com/flash/portfolio/biotech.html
MPM Investments in Medical Technology
http://www.mpmcapital.com/flash/portfolio/medtech.html
Company Financings
http://www.mpmcapital.com/flash/news/co_news/financings.html
-------------
Alta Partners
-------------
?Alta Partners currently manages seven venture fund programs
aggregating approximately $1.5 billion in committed capital.?
http://www.altapartners.com/
?Alta Partners is a venture capital firm founded in 1996, currently
managing seven venture fund programs aggregating approximately $1.5
billion in committed capital. Alta has funded approximately 130 life
sciences and information technology companies to date. The firm
invests in both early and later stage companies, through separate
stage-specific funds. Alta Partners is a successor to Burr, Egan,
Deleage & Co., which was founded in 1979.?
http://www.altapartners.com/about.html
Portfolio:
- Biotechnology and Biopharmaceutical companies
- Medical Technology and Health Care Companies
A brief description is given for each one.
http://www.altapartners.com/lifesciences.html
News
http://www.altapartners.com/news.html
-----------------
Domain Associates
-----------------
History
?Founded in 1985 to invest exclusively in emerging life sciences companies?
Portfolio
?Involved in formation of more than 170 companies over last 20 years.?
Assets
?$1.4 billion capital under management?
Locations
?Offices in Princeton, NJ and Laguna Niguel, CA? http://www.domainvc.com/
?Domain?s three major investment segments are pharmaceuticals,
specialty pharmaceuticals, and medical devices, while additional areas
of interest include biomaterials, bioinstrumentation, and
diagnostics.?
Domain?s investment activity can be grouped into three categories:
Venture Investing
Public Market Investing
Company Formation
http://www.domainvc.com/about.asp
Portfolio Companies (By Industry)
http://www.domainvc.com/Portfolio_Industry.asp
Active Portfolio companies
http://www.domainvc.com/Portfolio.asp?Filter=A
---------
HealthCap
---------
?HealthCap is a family of multi stage venture capital funds, investing
internationally in life sciences, with the Odlander Fredrikson Group
as their exclusive investments advisor. With committed capital
exceeding MSEK 6,300 HealthCap is the largest specialized provider of
venture capital within life sciences in the Nordic countries and one
of the largest independent actors in the sector in Europe.?
http://www.healthcap.se/
?They invest globally in pharmaceutical, biotechnology and medical
technology companies. Investments are made in early stage
opportunities as well as in more mature companies.?
?The three first funds have financed 55 companies. Approximately 20 of
the companies were start-ups and several have successfully completed
their Initial Public Offerings. HealthCap I, II and III are now fully
invested.?
http://www.healthcap.se/default.asp?page=docs/funds.asp
The Investments
See portfolio and brief description here:
http://www.healthcap.se/default.asp?page=docs/investments_frame.asp
--
3i
--
3i is a world leader in private equity and venture capital.
From early-stage venture capital to growth capital and buyouts, they
?invest ?1.3bn a year in some of the most exciting and ambitious
companies in the world.?
http://www.3i.com/
3i has a substantial portfolio spanning three continents. To find out
more about the companies that 3i has partnered with to deliver
success, please use the search facility below.
http://www.3i.com/ourportfolio/index.html
News
http://www.3i.com/media/index.html
---
HBM
---
?HBM BioVentures is a leading holding company in the human medicine,
biotech and medical technology industries. It enables investors to tap
in to a broadly diversified portfolio of private and primarily
small-cap public companies with high value creation potential in an
investment segment that is difficult to access. HBM BioVentures is
recognised as a complement to traditional pharmaceutical and biotech
investments. HBM BioVentures is an active investor which finances,
supports and shapes portfolio companies as a key partner.?
?HBM BioVentures focuses on companies with convincing product
pipelines and high value creation potential. The portfolio encompasses
both private and smaller public companies. HBM BioVentures invests in
attractively valued companies and, in some instances, assumes
strategic entrepreneurial responsibility. HBM BioVentures holds over
50 positions and aims to significantly increase its investment
volume.?
http://www.hbmbioventures.com/index_en.php
Portfolio
http://www.hbmbioventures.com/menu/indexen2.php
Financial Reports
http://www.hbmbioventures.com/menu/indexen3.php
--------
Montreux
--------
?Montreux is focused on investments in life science & healthcare
companies that target attractive market opportunities in the
pharmaceutical/biopharmaceutical, medical device, healthcare services
and life sciences industries.?
http://www.montreuxequity.com/sec/strategy
?Founded in 1993, Montreux Equity Partners, based in Menlo Park, CA,
is a private equity firm that invests in new and emerging life science
and healthcare companies. Montreux also selectively invests in
"special situations" companies. Montreux?s goal is to generate
long-term capital gains for both our investors and the entrepreneurs
that we support.
Montreux has over $190 million under management and is currently
investing out of funds with over $170 million in capital. Montreux
investment ranges from $2-$5 million in any given financing and up to
$12 million over the life cycle of the investment. We invest at all
stages of the company life cycle, investing in early, intermediate and
later stage private companies.?
http://www.montreuxequity.com/sec/about
Portfolio Companies
http://www.montreuxequity.com/sec/portfolio
----------------
SV Life Sciences
----------------
ILSF funds and IBT concentrate on investments within the United States
and Western Europe but will consider investments in other countries
where there is a well-developed life sciences sector.
ILSF funds typically invests in equity or near equity securities of
private companies, or, on occasion, small public companies. The focus
is to take a lead investor position in a small, strong investment
syndicates.
http://www.svlsa.com/pages/investment_criteria1.htm
?SVLS advised or managed funds invest in companies requiring funding
within the human life sciences sector including biotechnology and
pharmaceuticals, medical devices and instruments, healthcare IT and
services.?
?SVLS was established in 1993 and currently has offices in Boston,
London and San Francisco.?
?SVLS advises or manages four funds with total capital of
approximately $900m which invest in life science companies at all
stages of development. SVLS has 25 professionals who are able to
provide hands on scientific, advisory and financial support to their
portfolio companies.?
?Three of the funds are venture capital limited partnerships which
provide seed, start-up, early stage and expansion capital primarily to
private companies in North America and Europe. The most recently
raised fund, SV Life Sciences Fund III (ILSF III), closed on 30 May
2003 with total commitments of $402m. Typical investment size for
these funds is between $2m and $20m.?
?The fourth fund International Biotechnology Trust plc is a publicly
quoted investment trust listed on the London Stock Exchange (ticker
IBT), with total net asset value of approximately $99m (£56m as at 1
October 2005). IBT has an investment focus on later stage private and
smaller cap listed life sciences stocks and typical investment size is
$1 to $4m.?
http://www.svlsa.com/index.htm
Investments
http://www.svlsa.com/pages/investments.htm
----------
Abingworth
----------
?Abingworth is a long-established venture capital firm specialising in
unquoted and life science biomedical companies. With offices in
London, Cambridge (UK), Menlo Park and Boston, Abingworth is active on
both sides of the Atlantic and, in the past fifteen years, has backed
more than 80 developing life science/medical businesses. The majority
of these have gone on to public offerings or have merged or been
acquired by leading companies in the industry. Abingworth has funds
under management of over $700 million.?
http://www.abingworth.com/
?Abingworth's investments generally range between
$1-20 million averaging around $15 million per investment after all
rounds of private financing. Abingworth can also put together a
syndicate of investors to raise up to $50 million.?
http://www.abingworth.com/invest.htm
Portfolio Companies
http://www.abingworth.com/portfolio.jsp?ref=1
Company News
http://www.abingworth.com/news.jsp
------------------
Frazier Healthcare
------------------
?- Formed in 1991 to invest exclusively in emerging healthcare companies
- Biopharma, Medical Devices and Healthcare Services
- Building innovative healthcare companies while providing high returns
- Over 85 companies funded; 21 public; 14 acquired
- Over $1.2 billion of capital under management?
http://www.frazierhealthcare.com/
Portfolio
- Biopharma
- Medical Devices
- Healthcare Services
http://www.frazierhealthcare.com/portfolio/index.asp
Recent Financings
http://www.frazierhealthcare.com/news/recentfinancings.asp
============================================
Additional Information that may interest you
============================================
Venture Capital Investment in Health Industries Report
2005 - Q3
?Venture capital investment in the life sciences and health related
industries has stablized at approximately $1.5 for the past ten
quarters. This quarterly report summarizes investment activity in the
health related industries for Q3 2005 and provides detailed analysis
on a sub-sector basis."
The Venture Capital Investment in Health Industries Report is a comprehensive
analysis of venture capital investments specifically within the health industries.
The report uses survey data from the MoneyTree Survey, released by
PricewaterhouseCoopers, Thomson Venture Economics and the National
Venture Capital Association.
You will find a wealth of statistics, graphs and pie charts in this report.
http://www.pwcglobal.com/extweb/pwcpublications.nsf/docid/027CAA5EE6C25E90852570D200787D11
A full copy of the report is available for download at
http://healthcare.pwc.com/cgi-local/hcregister.cgi?link=reg/mt2005q3.pdf
FREE Registration is required
For example:
Page 6 - Health Industries Venture Capital Report Company Investments by Sector
Page 7 - Medical Devices and Equipment
Page 10-19 shows the following data for the different health industry sectors:
Investors
Investee Company
Financing
Amount Raised ($)
Nature of Business
====================================
Download the previous report as well.
Venture Capital Investment in Health Industries
Full Year and Q4 2004 Results
Download here:
http://www.pwcmoneytree.com/exhibits/Health_Industries_Report_Q4-Full_Year_2004.pdf
====================================
Equity by Industry
Equity Financings* for US Venture-Backed Companies, by Industry Group
(1997-4Q' 2003)
*Equity financings include cash investments by professional venture
capital firms, corporations, other private equity firms, and
individuals into companies that have received at least one round of
venture funding
Data is supplied for the following segments of the healthcare industry group:
- Biopharmaceuticals
- Healthcare Services
- Medical Devices
- Medical Information Systems
Download Excel Spreadsheet here:
Venture One
http://www.ventureone.com/ii/4Q03_Financing_Release.xls
====================================
Search criteria:
Venture Capital companies firms investments million billion health medical devices
I hope the information provided is helpful!
Best regards,
Bobbie7 |
,
0 Comments
)